BioIVT

This #WomensHistoryMonth, BioIVT’s #BookClub is turning the page on stories where science meets courage, curiosity, and impact with books that spotlight women who have shaped, and are still shaping, the life sciences. 📚 See the full list: hubs.ly/Q047J-x-0

Now is the time to schedule a meeting with our team at the #2026SOT Meeting & #ToxExpo! Our expert team is excited to discuss how we can help accelerate your research with high quality research products, services and support: hubs.ly/Q046TXZr0

Exploring #NAMs is one thing. Implementing them effectively is another. At BioIVT, we help you move from concept to application with the materials and insight to help you implement NAMs with confidence: hubs.ly/Q046V3BG0 #ADME #Toxicity #Biomarkers #Biospecimens

The March edition of our Resources Newsletter is out and features important updates & insights on #regulatory expectations, #NAMs, #DrugTransporters, allogeneic #CellTherapy, targeted #ProteinDegraders & more! hubs.ly/Q0478v2D0

Lauren Styles, Samuel Laborde, Nadine Zainudeen and Courtney Noah are at #AdvancedTherapies Congress booth #195 to help you source high quality RUO and GMP cellular starting material to achieve the consistency and reliability that are critical for therapeutic success!

The #ICHM12 guideline provides a globally harmonized framework for the investigation of #DrugInteractions, but how does it stand up in practice? Umehara et al. (2026) highlights practical challenges, translational gaps & opportunities for refinement: hubs.ly/Q046TVXb0

Hear Dr. Evans, Senior Scientific Advisor at BioIVT, present "Optimizing Pre-Analytical Variables for ctDNA, cfRNA/miRNA, EVs & Proteins: Practical Guidance for Trial-Ready #LiquidBiopsy" at the World CB & #CDxEurope Summit. Learn more: hubs.ly/Q046TWtw0

Unable to attend the Apr. 14 Boston symposium on #NewApproachMethodologies (#NAMs)? You can join the FDA & Industry Roundtable portion online! Learn more: In-person symposium details & registration: hubs.ly/Q046024z0 Online roundtable only: hubs.ly/Q04605gp0

Did you know that we offer #GLP1 cohorts collected from patients on the newest treatments and that our diverse normal and disease state #biospecimens can be segmented across five weight categories, #BMI &/or waist circumference and other demographic data? hubs.ly/Q04602GN0

Not all “normal” is created equal, especially in #neuroscience. 🧠 Undetected neurological changes or family history of #neurologicaldisease can quietly influence #biomarkers & skew results, but not with TruNormal® #biospecimens. Learn more: hubs.ly/Q046l21h0

Read Akadeum’s application note examining how variability in apheresis collection and #Tcell isolation directly impacts #CellTherapy manufacturing success, clinical outcomes, and regulatory risk: hubs.ly/Q045_ZZt0

New article in #DrugMetabolism & #Pharmacokinetics providing guidance on the effective application of transporter assays to improve #DrugInteractions prediction, regulatory decision-making, & #PrecisionMedicine: hubs.ly/Q045__cz0 #DrugTransporters #ADME #DMPK

As #exosomes become increasingly scalable, the scientific conversation has shifted from the possibility of #Therapeutic, #Diagnostics & #PersonalCare applications to real-world implementation questions around standardization & utilization strategies: hubs.ly/Q045_VwK0

For #InternationalWomensDay, we’re celebrating the women shaping the future of our industry, strengthening the infrastructure, mentorship & collaboration needed to support the breakthroughs and leaders of tomorrow: hubs.ly/Q045Z3Dj0 #IWD2026 #WomenInSTEM #LeadHERship

At BioIVT, we rely on a wide range of diverse donor samples to fuel scientific innovation, across age, ethnicity, gender, and health status. Donating is easy, impactful, and comes with compensation. Learn more! US: hubs.ly/Q0458zyJ0 UK: hubs.ly/Q0458BDX0

#TargetedProteinDegradation is an emerging and highly promising novel strategy using the cell’s own machinery to remove previously undruggable proteins, opening new therapeutic paths. However, development faces a number of hurdles: hubs.ly/Q045m40D0

We’re at #FestivalofBiologics booth #305 to help you source high quality normal & disease state biospecimens to match your specific needs, including diverse tissue specimens, cellular preparations & biofluids, or research services from ADME & bioanalysis to NGS screening.

Our next #NewApproachMethodologies (#NAMs) Symposium and #FDA & Industry Roundtable have been announced! View the details and register for the in-person symposium or online roundtable: hubs.ly/Q0458ttw0 #MassBioHub #MassBio #BostonBio #Cambridge

Our #2026SOT presentations include: • Characterization Drives #CIVM Qualification • HLA-Typed #PBMCs to Detect Immune-Mediated #DILI • #AI Algorithms for #Hepatocyte Counting • #InVitro Liver Test System Intrinsic Clearance Trends View details: hubs.ly/Q0458JqH0

Our team is passionate about supporting the development of therapies for #RareDiseases and the millions of patients and families they affect. Read about what drives Brian Ogilvie, PhD, VP of Scientific Consulting: hubs.ly/Q0449x9k0 #ItsPersonal #WhyWeDoWhatWeDo